Evaluating the Implementation and Clinical Effectiveness of an Innovative Digital First Care Model for Behavioral Health Using the RE-AIM Framework: Quantitative Evaluation.

access to care clinical effectiveness digital mental health interventions implementation practice-oriented research

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
30 Oct 2024
Historique:
received: 13 11 2023
accepted: 11 09 2024
revised: 12 04 2024
medline: 31 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

In the United States, innovation is needed to address the increasing need for mental health care services and widen the patient-to-provider ratio. Despite the benefits of digital mental health interventions (DMHIs), they have not been effective in addressing patients' behavioral health challenges as stand-alone treatments. This study evaluates the implementation and effectiveness of precision behavioral health (PBH), a digital-first behavioral health care model embedded within routine primary care that refers patients to an ecosystem of evidence-based DMHIs with strategically placed human support. Patient demographic information, triage visit outcomes, multidimensional patient-reported outcome measure, enrollment, and engagement with the DMHIs were analyzed using data from the electronic health record and vendor-reported data files. The RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework was used to evaluate the implementation and clinical effectiveness outcomes of PBH. PBH had a 47.58% reach rate, defined as patients accepting the PBH referral from their behavioral health integrated clinician. PBH patients had high DMHI registration rates (79.62%), high activation rates (76.54%), and high retention rates at 15 days (57.69%) and 30 days (44.58%) compared to literature benchmarks. In total, 74.01% (n=168) of patients showed clinical improvement, 22.47% (n=51) showed no clinical change, and 3.52% (n=8) showed clinical deterioration in symptoms. PBH had high adoption rates, with behavioral health integrated clinicians referring on average 4.35 (SD 0.46) patients to PBH per month and 90%-100% of clinicians (n=12) consistently referring at least 1 patient to PBH each month. A third (32%, n=1114) of patients were offered PBH as a treatment option during their triage visit. PBH as a care model with evidence-based DMHIs, human support for patients, and integration within routine settings offers a credible service to support patients with mild to moderate mental health challenges. This type of model has the potential to address real-life access to care problems faced by health care settings.

Sections du résumé

BACKGROUND BACKGROUND
In the United States, innovation is needed to address the increasing need for mental health care services and widen the patient-to-provider ratio. Despite the benefits of digital mental health interventions (DMHIs), they have not been effective in addressing patients' behavioral health challenges as stand-alone treatments.
OBJECTIVE OBJECTIVE
This study evaluates the implementation and effectiveness of precision behavioral health (PBH), a digital-first behavioral health care model embedded within routine primary care that refers patients to an ecosystem of evidence-based DMHIs with strategically placed human support.
METHODS METHODS
Patient demographic information, triage visit outcomes, multidimensional patient-reported outcome measure, enrollment, and engagement with the DMHIs were analyzed using data from the electronic health record and vendor-reported data files. The RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework was used to evaluate the implementation and clinical effectiveness outcomes of PBH.
RESULTS RESULTS
PBH had a 47.58% reach rate, defined as patients accepting the PBH referral from their behavioral health integrated clinician. PBH patients had high DMHI registration rates (79.62%), high activation rates (76.54%), and high retention rates at 15 days (57.69%) and 30 days (44.58%) compared to literature benchmarks. In total, 74.01% (n=168) of patients showed clinical improvement, 22.47% (n=51) showed no clinical change, and 3.52% (n=8) showed clinical deterioration in symptoms. PBH had high adoption rates, with behavioral health integrated clinicians referring on average 4.35 (SD 0.46) patients to PBH per month and 90%-100% of clinicians (n=12) consistently referring at least 1 patient to PBH each month. A third (32%, n=1114) of patients were offered PBH as a treatment option during their triage visit.
CONCLUSIONS CONCLUSIONS
PBH as a care model with evidence-based DMHIs, human support for patients, and integration within routine settings offers a credible service to support patients with mild to moderate mental health challenges. This type of model has the potential to address real-life access to care problems faced by health care settings.

Identifiants

pubmed: 39476366
pii: v26i1e54528
doi: 10.2196/54528
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e54528

Informations de copyright

©Samuel S Nordberg, Brittany A Jaso-Yim, Pratha Sah, Keke Schuler, Mara Eyllon, Mariesa Pennine, Georgia H Hoyler, J Ben Barnes, Lily Hong Murillo, Heather O'Dea, Laura Orth, Elizabeth Rogers, George Welch, Gabrielle Peloquin, Soo Jeong Youn. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 30.10.2024.

Auteurs

Samuel S Nordberg (SS)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Brittany A Jaso-Yim (BA)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Pratha Sah (P)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Keke Schuler (K)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Mara Eyllon (M)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Mariesa Pennine (M)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Georgia H Hoyler (GH)

United Health Group, Minnetonka, MN, United States.

J Ben Barnes (JB)

Reliant Medical Group, OptumCare, Worcester, MA, United States.
University of Massachusetts Chan School of Medicine, Worcester, MA, United States.

Lily Hong Murillo (LH)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Heather O'Dea (H)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Laura Orth (L)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Elizabeth Rogers (E)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

George Welch (G)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Gabrielle Peloquin (G)

Reliant Medical Group, OptumCare, Worcester, MA, United States.

Soo Jeong Youn (SJ)

Reliant Medical Group, OptumCare, Worcester, MA, United States.
Harvard Medical School, Boston, MA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH